SEARCH

SEARCH BY CITATION

References

  • 1
    Sakaguchi S, Regulatory T. Cells: key controllers of immunological self-tolerance. Cell 2000;101: 4558.
  • 2
    Belghith M, Bluestone JA, Barriot S, Mégret J, Bach JF, Chatenoud L. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003;9: 12028.
  • 3
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;160: 115164.
  • 4
    Saoudi S, Seddon B, Fowell D, Mason D. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J Exp Med 1996;184: 23938.
  • 5
    Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160: 12128.
  • 6
    Itoh M, Takahashi T, Sakaguchi N et al. Thymus and autoimmunity. production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999;162: 531726.
  • 7
    Bagavant H, Thompson C, Ohno K, Setiady Y, Tung KSK. Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease. Int Immunol 2002;14: 1397406.
  • 8
    Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleulin-10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192: 121322.
  • 9
    Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD25+CD4+ T cells with regulatory properties from human blood. J Exp Med 2001;193: 130310.
  • 10
    Stephens LA, Mottet C, Mason D, Powrie F. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001;31: 124754.
  • 11
    Sullivan KE, McDonald-McGinn D, Zackai EH. CD4+CD25+ T-cell population in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol 2002;9: 112931.
  • 12
    Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003;33: 21523.
  • 13
    Vincent A. Uravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002;2: 797804.
  • 14
    Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797810.
  • 15
    Gronseth GS, Barohn RJ. Practice parameter: thymectomy for the Quality Standards. Neurology 2000;55: 715.
  • 16
    Alpert LI, Paptestas A, Kark A, Osserman RS, Osserman K. A histological reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol 1971;91: 5561.
  • 17
    Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E. Characterization of human CD25+CD4+ T cells in thymus, cord and adult blood. Immunology 2002;106: 1909.
  • 18
    Taylor PA, Noelle RJ, Blazar BR. CD4+CD25+ regulatory T cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001;193: 13117.
  • 19
    Lohr J, Knoechel B, Jiang S, Sharpe AH, Abbas AK. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol 2003;4: 6649.
  • 20
    Oosterhuis HHGH. Studies in myasthenia gravis. Part 1. A clinical study of 180 patients. J Neurol Sci 1964;1: 51246.
  • 21
    Sakaguchi SN, Sakaguch NJ, Shimizu JS et al. Takahashi T. Immunologic tolerance maintained by CD4+CD25+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182: 1832.
  • 22
    Steitz J, Bruck J, Lenz J, Knop J, Tuting T. Depletion of CD4+CD25+ T cells and treatment wit tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced CD8(+) T cell-dependent immune defense of B16 melanoma. Cancer Res 2001;61: 86436.
  • 23
    Woo EY, Yeh H, Chu CS et al. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002;168: 42726.
  • 24
    Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196: 4016.
  • 25
    Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002;196: 38999.
  • 26
    Jiang S, Lechler RI. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am J Transplant 2003; 3: 51624.
  • 27
    Waldmann TA. The interleukin-2 receptor. J Biol Chem 1991;266: 26814.
  • 28
    Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001;167: 124553.
  • 29
    Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN. Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001;31: 112231.
  • 30
    Åhlberg R, Yi Q, Pirskanen R et al. The effect of thymectomy on autoreactive T- and B-lymphocytes in myasthenia gravis. J Neuroimmunol 1997;74: 4554.
  • 31
    McHugh RS, Shevach EM. Deletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002;168: 597983.
  • 32
    Bardos T, Czipri M, Vermes C, Finnegan A, Mikecz K, Zhang J. CD4+CD25+ immunoregulatory T cells may not be involved in controlling autoimmune arthritis. Arthritis Res Ther 2003;5: 10613.
  • 33
    Putheti P, Soderstrom M, Link H, Huang YM. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis. J Neuroimmunol 2003;144: 12531.
  • 34
    Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr Opin Immunol 2003;15: 6906.
  • 35
    Fu S, Yopp AC, Mao X et al. CD4+CD25+CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004;4: 6578.